BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ViaCyte, Inc. (Formerly Known as Novocell, Inc.) 

3550 General Atomics Court
Building 2, Room 503
San Diego  California  92121  U.S.A.
Phone: 858-455-3708 Fax: 858-455-3962


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Juvenile Diabetes Research Foundation Partner ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Announces Key Project Milestone To Advance Innovative Encapsulated Cell Replacement Therapy Product For Type 1 Diabetes 7/17/2014 11:01:59 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Files Investigational New Drug Application And Device Master File With FDA For Novel Cell Replacement Therapy Product Candidate Designed To Treat Patients With Type 1 Diabetes 7/17/2014 9:54:31 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Achieves Significant Milestone With ISO 13485:2003 Certification For Its Encaptra Drug Delivery System 7/8/2014 9:56:36 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Appoints Mark Foletta, Former CFO Of Amylin Pharmaceuticals, Inc. (AMLN), To Its Board Of Directors 12/19/2013 8:01:31 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) To Present At The 25th Piper Jaffray Healthcare Conference 12/3/2013 8:03:31 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Granted Over 20 Patents in 2013 Further Establishing the Company as a Leader in the Field of Regenerative Medicine 10/30/2013 8:56:18 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) to Present at the JDRF 8th Annual T1D Global Path to a Cure Symposium 10/16/2013 10:32:15 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) to Present Update on VC-01™ Combination Product Development at 2013 Stem Cell Meeting on the Mesa 10/11/2013 6:09:51 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Nabs $10.6 Million in a Private Financing 7/10/2013 6:54:54 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.)'s Role as a Leading Cell Therapy Company Bolstered With the Issuance of 20 Patents in 2012 1/31/2013 9:01:40 AM
12345